Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 10, 2026
Why Did Arq, Inc. (ARQ) Stock Fall -27.50% Today?

Why Did Arq, Inc. (ARQ) Stock Fall -27.50% Today?

Key Takeaways

  • Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32
  • The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024
  • A $44.8 million non-cash impairment charge tied to the idling of its Corbin facility amplified investor alarm
  • The company announced an indefinite pause on Granular Activated Carbon (GAC) production pending a comprehensive engineering review
  • Arq's 2026 revenue guidance of $120–$125 million came in well below the analyst consensus of $136.94 million
  • The abrupt departure of CFO Jay Voncannon, effective immediately, added a governance shock to an already damaging earnings narrative

Opening Summary

Arq, Inc. (ARQ) is a Colorado-based environmental technology company that produces activated carbon products — including Powdered Activated Carbon (PAC) and Granular Activated Carbon (GAC) — used in air emissions control, water treatment, and soil remediation across the United States and Canada. Shares of ARQ collapsed approximately 27.50% in premarket trading on March 10, 2026, following a series of deeply negative disclosures released after the close on March 9. The stock slid from its prior session close of approximately $3.20 to around $2.32, reflecting broad investor shock at the confluence of an earnings miss, a massive asset impairment, a production halt, a guidance reset, and an unexpected CFO exit.

Earnings Miss and Widening Losses

Arq reported Q4 2025 net loss of $50.0 million, compared to a net loss of just $1.3 million in Q4 2024 — a year-over-year deterioration that far exceeded what analysts had anticipated. On a per-share basis, ARQ posted a quarterly loss of $0.07 versus the consensus estimate of a loss of $0.05, a miss that compounded the company's third-quarter stumble in November 2025, when it had already delivered an EPS print 200% below expectations. For the full year 2025, net loss widened to $52.6 million from $5.1 million in 2024, erasing much of the goodwill built during earlier quarters. Revenue for Q4 2025 did increase 8.7% year-over-year to $29.4 million, but gross margin compressed sharply to 13.6% from 36.3% a year earlier, driven by elevated costs tied to GAC start-up activities.

The GAC Production Halt and Impairment Charge

The most structurally damaging disclosure was Arq's announcement that it is pausing all GAC production for an indefinite period to conduct a comprehensive engineering and production process optimization review. Independent testing found that the facility's thermal oxidizer — a core piece of equipment — could only support approximately 15 million pounds of annual output, far below the targets originally embedded in the growth thesis. Arq recorded a $44.8 million non-cash impairment charge in Q4 related to the temporary idling of its Corbin production facility, a write-down that signals the asset has become economically impaired under current conditions. No GAC contribution is expected in 2026, effectively stranding a business line that had been positioned as ARQ's primary growth engine.

Guidance Well Below Consensus

Arq's inaugural 2026 revenue guidance of $120–$125 million implies near-zero growth from its record 2025 result of approximately $120.3 million, and came in considerably below the Wall Street consensus of $136.94 million. Adjusted EBITDA guidance of $17–$20 million similarly disappointed investors who had been expecting the GAC ramp-up to drive meaningful margin expansion. The guidance confirms that Arq's 2026 financial plan rests entirely on its legacy PAC business — a profitable but slower-growth segment — while management works through the engineering overhaul of GAC. For growth-oriented investors who had priced in a continuation of the expansion narrative, the guidance represented a fundamental reset of the investment case.

CFO Departure Adds Governance Concern

Compounding the earnings and operational pressures, Arq disclosed that CFO Jay Voncannon will no longer serve in his role, effective immediately. Leadership transitions are typically destabilizing in the middle of a financial reset, and the abruptness of the announcement — with no successor named — raised questions about internal stability at a critical juncture. The departure follows a string of challenging quarterly results and comes as the company faces its most significant operational and strategic challenge since it pivoted toward GAC production.

Market Context and Trading Activity

The premarket sell-off in ARQ came against a backdrop of heightened sensitivity to earnings misses and guidance cuts in small-cap industrials and environmental technology names. The magnitude of the move — approaching 28% — reflects the severity of the combined negative catalysts rather than any broad sector rotation or macro-driven pressure. ARQ's beta of approximately 3.37 indicates the stock is structurally prone to outsized moves on fundamental news. Volume was expected to be significantly elevated relative to average daily trading levels as institutional and retail investors reacted to the earnings release. Prior to this report, the stock had already declined more than 36% over the trailing twelve months, reflecting persistent GAC-related concerns that had been building since late 2024.

Trending AI Robots

For traders looking to navigate volatile situations like today's move in ARQ, Tickeron's Trending AI Robots page offers a curated view of the platform's best-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers, spanning a wide range of strategies, timeframes, performance metrics, and asset types — from momentum and swing trading to mean-reversion and sector-focused approaches. The Trending section surfaces only those bots demonstrating the strongest real-time performance, making it a practical starting point for traders seeking algorithmic tools that are actively working in today's environment. Investors interested in systematic, data-driven approaches to markets like this may find the page a valuable resource.

What Comes Next for ARQ

The most critical near-term catalyst for ARQ is the outcome of the GAC engineering review, which management expects to conclude later in 2026. If the thermal oxidizer can be modified to support economic output levels, the original growth thesis could be partially restored; a more costly redesign or full abandonment would be a further blow to the long-term investment case. Investors will also be watching whether ARQ can sustain PAC pricing and volume in 2026 to meet its standalone guidance without GAC contributions — a task made more uncertain by the leadership vacuum created by the CFO departure. Analysts who had maintained Buy ratings with price targets near $8.00 will likely revisit their models materially following today's disclosures. Broader sector dynamics, including regulatory demand for water treatment solutions, remain a potential long-term tailwind, but near-term execution risk is elevated.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: ARQ

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ARQ sees MACD Histogram crosses below signal line

ARQ saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 39 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARQ as a result. In 76 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

ARQ moved below its 50-day moving average on September 14, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for ARQ entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for ARQ crossed bullishly above the 50-day moving average on September 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +4.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARQ advanced for three days, in 201 of 256 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

ARQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. ARQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.532) is normal, around the industry mean (12.368). P/E Ratio (156.333) is within average values for comparable stocks, (161.882). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (0.968). Dividend Yield (0.000) settles around the average of (0.008) among similar stocks. P/S Ratio (0.716) is also within normal values, averaging (236.722).

The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Industry description

Companies in the industrial specialties industry process basic materials and minerals into various specialty products, such as flat and safety glass, fire retardant products, paints and coatings. Examples of companies operating in this industry are Sherwin-Williams Company, PPG Industries, Inc. and RPM International Inc.

Market Cap

The average market capitalization across the Industrial Specialties Industry is 2.2B. The market cap for tickers in the group ranges from 281.2K to 23.04B. VLTO holds the highest valuation in this group at 23.04B. The lowest valued company is FLMP at 281.2K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Specialties Industry was -5%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -7%. BCHT experienced the highest price growth at 28%, while PCTTU experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Industrial Specialties Industry was 208%. For the same stocks of the Industry, the average monthly volume growth was 86% and the average quarterly volume growth was 32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 74
P/E Growth Rating: 79
Price Growth Rating: 65
SMR Rating: 89
Profit Risk Rating: 91
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
ARQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company, which engages in clean coal technology

Industry IndustrialSpecialties

Profile
Details
Industry
Industrial Machinery
Address
8051 East Maplewood Avenue
Phone
+1 720 598-3500
Employees
202
Web
https://www.arq.com
Interact to see
Advertisement
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.